fda regulations on semaglutide Safe use of compounded GLP products 🚨 FDA Moves to Permanently

In clinical trials, Semaglutide resulted in an average weight loss of 15% over 68 weeks, while Tirzepatide achieved up to 20% over 72 weeks, both paired with diet and exercise

A more concentrated medication requires fewer units to deliver the same dose

For those struggling with nausea from semaglutide, Zofran can be a valuable tool to manage this side effect

Despite some improvements in Alzheimer s-related biomarkers, the drug failed to achieve statistical significance on the primary endpoint of cognitive decline, leaving both researchers and patients disappointed

Heres why: They can actually exacerbate uncomfortable gastrointestinal (GI) side effects of the drug, such as diarrhea, nausea, and vomiting